Galiximab pharmacokinetics determined in patients with relapsed or refractory follicular NHL

被引：0
|
作者：
Woodworth, J
Peltz, EH
Leonard, JP
Friedberg, J
Younes, A
Fisher, D
Gordon, L
Leigh, BR
机构：
[1] Biogen Idec, Cambridge, MA USA
[2] Well Cornell Med Ctr, New York, NY USA
[3] Univ Rochester, Rochester, NY USA
[4] MDACC, Houston, TX USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Northwestern Univ, Chicago, IL 60611 USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [41] Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
    Linton, Kim M.
    Vitolo, Umberto
    Jurczak, Wojciech
    Lugtenburg, Pieternella J.
    Gyan, Emmanuel
    Sureda, Anna
    Christensen, Jacob Haaber
    Hess, Brian
    Tilly, Herve
    Cordoba, Raul
    Lewis, David John
    Okada, Craig
    Hutchings, Martin
    Clausen, Michael Roost
    Sancho, Juan-Manuel
    Cochrane, Tara
    Leppa, Sirpa
    Chamuleau, Martine E. D.
    Gernhardt, Diana
    Altintas, Isil
    Liu, Yan
    Ahmadi, Tahamtan
    Dinh, Minh H.
    Hoehn, Daniela
    Favaro, Elena
    Elliott, Brian
    Thieblemont, Catherine
    Vose, Julie M.
    LANCET HAEMATOLOGY, 2024, 11 (08): : e593 - e605
  • [42] BENDAMUSTINE PHARMACOKINETICS (PK) IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA
    Darwish, M.
    Megason, G.
    Bond, M.
    Hellriegel, E.
    Robertson, P., Jr.
    Clementi, R.
    Phillips, L.
    Grasela, T.
    Fraser, C.
    HAEMATOLOGICA, 2012, 97 : 488 - 488
  • [43] POPULATION PHARMACOKINETICS OF TEMSIROLIMUS IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY SOLID TUMORS
    Liao, S.
    Spunt, S. L.
    Shapiro, M.
    Boni, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 179 - 180
  • [44] Pharmacokinetics (PK) of bendamustine in pediatric patients with relapsed/refractory acute leukemia
    Darwish, Mona
    Megason, Gail C.
    Bond, Mary
    Hellriegel, Edward
    Robertson, Philmore
    Clementi, Regina
    Phillips, Luann
    Grasela, Thaddeus
    Fraser, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Prognostic Factors of Autologous Transplantation in the Treatment of Patients With Relapsed/Refractory Follicular Lymphoma
    Jona, Adam
    Kenyeres, Anna
    Kiss, Evelin
    Illes, Arpad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S384 - S385
  • [46] Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments
    Thomas, Caitlin
    Marsh, Kevin
    Trapali, Myrto
    Krucien, Nicolas
    Worth, Gavin
    Cockrum, Paul
    Lycett, Debra
    CANCER MEDICINE, 2024, 13 (19):
  • [47] Updates to the Management of Patients With Relapsed or Refractory Indolent Follicular and Marginal Zone Lymphomas
    LaCasce, Ann S.
    Noy, Ariela
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 578 - 580
  • [48] Phase II study of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymhoma (NHL)
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, F
    Bleyer, A
    BLOOD, 2003, 102 (11) : 639A - 640A
  • [49] Yttrium 90 ibritumomab tiuxetan is safe and effective in older patients with relapsed or refractory NHL.
    Schilder, RJ
    Emmanouilides, C
    Vo, K
    Witzig, TE
    Flinn, I
    Darif, M
    Gordon, L
    Molina, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 575S - 575S
  • [50] Epcoritamab SC With Rituximab plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma, Including Patients With POD24: Updated Results From EPCORE NHL-2
    Merryman, Reid W.
    Belada, David
    Sureda, Anna
    Leppa, Sirpa
    Vermaat, Joost S. P.
    Holte, Harald
    Hutchings, Martin
    Lugtenburg, Pieternella
    de Vos, Sven
    Abrisqueta, Pau
    Nijland, Marcel
    Christensen, Jacob Haaber
    Wahlin, Bjorn E.
    Linton, Kim M.
    Wang Liwei
    Abbas, Aqeel
    Rana, Ali
    Quadri, Syed
    Falchi, Lorenzo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S37 - S38
12345